NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S: Financial statements 2016
CVR: 33249098
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S (CVR 33249098) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 15,990,692 and a net result of DKK 11,052,541 compared with DKK 45,386,395 the year before. That is a decrease of 73.5% compared with the year before. Equity in the 2016 report amounted to DKK 12,034,318. The solvency ratio was 17.2%.
- Gross Profit
- DKK 15,990,692
- Profit/Loss
- DKK 11,052,541
- Equity
- DKK 12,034,318
- Total Assets
- DKK 70,142,304
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 16 mio. | 11.1 mio. | 12 mio. | - |
| 2015 | - | 60.4 mio. | 45.4 mio. | 46 mio. | - |
| 2014 | - | 42 mio. | 32.4 mio. | 38.6 mio. | - |
| 2013 | - | 4.2 mio. | 3.2 mio. | 6.2 mio. | - |
| 2012 | - | - | - | 500 t. | - |
Official annual report
Find more companies like NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S has published its annual report for 2015. Gross profit came to DKK 60,441,747, and the net result was DKK 45,386,395.
About NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S
NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S was a Danish company of the type Aktieselskab based in Herlev, founded in 2010. The company has been dissolved on 25 May 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. According to the 2019 annual report, the company had an average of 0 employees. In 2019, the company reported a gross profit of DKK 248,136 and a net result of DKK 164,772 compared with DKK 954,488 the year before. Equity in the 2019 report amounted to DKK 725,098.